Gene: TEP1
Official Full Name: telomerase associated protein 1provided by HGNC
Gene Summary: This gene product is a component of the ribonucleoprotein complex responsible for telomerase activity which catalyzes the addition of new telomeres on the chromosome ends. The telomerase-associated proteins are conserved from ciliates to humans. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35055 | TEP1 Knockout cell line (HeLa) | Human | TEP1 | 1:3~1:6 | Negative | Online Inquiry |
KO35056 | TEP1 Knockout cell line (HCT 116) | Human | TEP1 | 1:2~1:4 | Negative | Online Inquiry |
KO35057 | TEP1 Knockout cell line (HEK293) | Human | TEP1 | 1:3~1:6 | Negative | Online Inquiry |
KO35058 | TEP1 Knockout cell line (A549) | Human | TEP1 | 1:3~1:4 | Negative | Online Inquiry |
TEP1 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the functions and roles of the TEP1 gene, a member of the protein-coding gene family involved in various cellular processes, including immune response and cellular signaling. These cell lines have been created using state-of-the-art CRISPR-Cas9 technology, which allows for precise and efficient modifications in the genomic DNA, resulting in a complete knockout of the TEP1 gene. This targeted approach enables researchers to observe the phenotypic and molecular changes that occur upon loss of TEP1 function, thereby elucidating its biological significance.
The key functions of the TEP1 gene have been linked to modulation of immune responses, making these knockout cell lines valuable tools for investigating how TEP1 contributes to various pathophysiological conditions and cancer immunology. Researchers can conduct comparative analyses between TEP1 knockout and wild-type cell lines to identify altered metabolic pathways, protein expression profiles, and cellular behaviors that are affected due to the absence of TEP1.
In scientific research and clinical settings, TEP1 Gene Knockout Cell Lines serve as essential models for drug discovery, disease modeling, and understanding the genetic basis of immune disorders. These cell lines can facilitate high-throughput screening for potential therapeutics that could target related pathways, aiding in the development of novel treatments.
What sets TEP1 Gene Knockout Cell Lines apart from traditional knockout models is the precision and efficiency of the CRISPR-Cas9 methodology, which significantly reduces the time and resources needed for gene editing. Additionally, the reliability of these cell lines ensures reproducible results, providing researchers with confidence in their experimental data.
For researchers and clinicians focused on the intersection of genetics and immunology, the TEP1 Gene Knockout Cell Lines are indispensable. Their ability to unlock new insights into immune system dynamics and disease mechanisms can ultimately lead to groundbreaking advancements in therapeutic interventions.
Our company specializes in genetic modifications and cellular characterization, providing high-quality biological products developed by a team of experienced scientists committed to advancing research excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.